semaglutide pad 🔴The STRIDE trial! 👟⤵️ 🔹The STRIDE trial demonstrated that significantly improves function, symptoms, and health-related QoL in patients with symptomatic #cvPAD and T2DM STRIDE trial analysis confirms potential

Notably, reduced TFEB nuclear localization is closely associated with human pancreatitis

Roman P, Carrillo-Trabaln F, Snchez-Labraca N, Caadas F, Estvez AF, Cardona D

For most men pursuing ongoing optimization, home-injectable glutathione is more practical and sustainable

Implications of the trial results for Ozempic and GLP-1 drugs The results of the trial could expand Ozempics (and eventually other GLP-1 receptor agonists) indications to treat many more conditions for people with type 2 diabetes

They recommend patients stop semaglutide and similar medications well in advance of any sedated procedures

Semaglutide is a biologic peptide too complex to replicate exactly so competing versions are called biosimilars